PALISADE CAPITAL MANAGEMENT, LP Q2 2022 Filing

Filed August 10, 2022

Portfolio Value

$3.7B

Holdings

422

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (422 positions)

#	Stock	Shares	Value	% Portfolio
401	ABTABBOTT LABS	2,850	$310K	0.01%
402	IJHISHARES TR	1,306	$295K	0.01%
403	QDELQUIDELORTHO CORP	3,000	$292K	0.01%
404	—THERAVANCE BIOPHARMA INC	308,000	$286K	0.01%
405	GMGENERAL MTRS CO	8,800	$279K	0.01%
406	ACNACCENTURE PLC IRELAND	957	$266K	0.01%
407	BKNGBOOKING HOLDINGS INC	140	$245K	0.01%
408	LLYLILLY ELI & CO	745	$242K	0.01%
409	—SUPERNUS PHARMACEUTICALS	238,000	$231K	0.01%
410	MUMICRON TECHNOLOGY INC	4,050	$224K	0.01%
411	—APOLLO COML REAL ESTATE FIN	220,000	$216K	0.01%
412	RSPINVESCO EXCHANGE TRADED FD T	1,602	$215K	0.01%
413	RBBNRIBBON COMMUNICATIONS INC	70,000	$213K	0.01%
414	BLNKBLINK CHARGING CO	10,000	$165K	0.00%
415	HOODROBINHOOD MKTS INC	20,000	$164K	0.00%
416	MITKMITEK SYS INC	16,000	$148K	0.00%
417	LYFTLYFT INC	10,200	$135K	0.00%
418	AALAMERICAN AIRLS GROUP INC	10,500	$133K	0.00%
419	GOEVQCANOO INC	40,000	$74K	0.00%
420	CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC	80,000	$55K	0.00%
421	—SYNCHRONOSS TECHNOLOGIES INC	35,000	$40K	0.00%
422	—MANDIANT INC	15,000	$14K	0.00%

PreviousPage 5 of 5